From Name:
From Email:
To Name:
To Email:

Optional Message:


Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia

from MDLinx

In this study of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial including 12,090 people with dysglycemia who were at high risk of cardiovascular diseases, had an ankle-brachial index either greater than 0.9 or 0.9 or less, and followed for 6.2 years, researchers determined the if insulin glargine or omega-3 supplements have any impact on the incidence and progression of peripheral artery disease. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063